BRIEF published on 12/02/2024 at 13:35, 1 year 8 months ago Gerresheimer étend sa production de seringues en verre à Skopje Investissement Industrie Pharmaceutique Seringues En Verre Gerresheim Agrandissement De Skopje
PRESS RELEASE published on 12/02/2024 at 13:30, 1 year 8 months ago Gerresheimer builds new production capacities for glass syringes at Skopje site Gerresheimer is expanding its production capacity in Skopje, North Macedonia by constructing a new production hall for glass syringes, investing over EUR 100 million and creating around 250 new jobs Expansion Production Capacity Gerresheimer Glass Syringes Skopje
BRIEF published on 10/14/2024 at 11:05, 1 year 10 months ago Solar Power Initiative at Gerresheimer's Belgium Site Energy Transition Solar Energy CO2 Reduction Renewable Strategy Cosmetic Packaging
BRIEF published on 10/14/2024 at 11:05, 1 year 10 months ago Initiative d'énergie solaire sur le site belge de Gerresheimer Transition Énergétique Énergie Solaire Réduction Des Émissions De CO2 Stratégie Renouvelable Emballage Cosmétique
PRESS RELEASE published on 10/14/2024 at 11:00, 1 year 10 months ago Solar power for Gerresheimer site in Momignies, Belgium Gerresheimer installs 2.3 MWp solar power system at Momignies site in Belgium, aiming for 100% renewable electricity by 2030. Key steps in ESG strategy ESG Renewable Electricity Gerresheimer Solar Power Momignies
BRIEF published on 09/30/2024 at 16:26, 1 year 10 months ago Gerresheimer AG Adjusts Growth Guidance for 2024 and 2025 Adjusted EBITDA Revenue Forecast Gerresheimer AG Growth Guidance Vial Market
BRIEF published on 09/30/2024 at 16:26, 1 year 10 months ago Gerresheimer AG ajuste ses prévisions de croissance pour 2024 et 2025 EBITDA Ajusté Gerresheimer AG Prévisions De Revenus Orientation De La Croissance Marché Aux Fioles
PRESS RELEASE published on 09/30/2024 at 16:21, 1 year 10 months ago EQS-Adhoc: Gerresheimer AG: Adjustment of growth guidance for 2024 and 2025 Gerresheimer AG adjusts growth guidance for 2024 and 2025 due to market recovery challenges and production halt. Details on revenue, EBITDA, and EPS changes provided EBITDA Revenue Gerresheimer AG EPS Growth Guidance
BRIEF published on 09/26/2024 at 12:35, 1 year 10 months ago Gerresheimer, Stevanato Group, and SCHOTT Pharma Form "Alliance for RTU" RTU Containers Pharmaceutical Efficiency Operational Risks Aseptic Filling Technologies Pharma Safety
BRIEF published on 09/26/2024 at 12:35, 1 year 10 months ago Gerresheimer, Stevanato Group et SCHOTT Pharma forment une « Alliance pour la RTU » Efficacité Pharmaceutique Conteneurs RTU Risques Opérationnels Technologies De Remplissage Aseptique Sécurité Pharmaceutique
Published on 08/15/2026 at 00:50, 7 hours 14 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 7 hours 49 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 8 hours 19 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 8 hours 39 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 9 hours 4 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/14/2026 at 18:15, 13 hours 49 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 15 hours 59 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/14/2026 at 15:29, 16 hours 35 minutes ago Tradegate AG publishes its half-year report
Published on 08/13/2026 at 18:00, 1 day 14 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 14 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 14 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 14 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 14 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
